Get email alerts when ORKA insiders make a move — free, no credit card

ORKA Insider Trading & Form 4 Activity

Oruka Therapeutics, Inc.
Last filing: Oct 20, 2026·4 days ago
BEARISH · LAST 90 DAYS
0%
buyers
$0
0 buys
$421K
3 sells
-$421K
net selling
3
insiders
Tracking ORKA insiders takes 3 seconds. Get free alerts →
ACTIVE SELLING CLUSTER

3 insiders sold a combined $421K of ORKA on Sep 15, 2026.

Quinlan Paul T, Klein Lawrence Otto, Sandler Laura Lee

Don't miss the next ORKA cluster. Tracenotes detected this one — get the next alert free.

Net flow — last 12 months

Monthly net of insider buys minus sells. Green months indicate net buying; red months indicate net selling.

Most active insiders

Ranked by total transaction value over the last 90 days.

INSIDERBOUGHTSOLDNET
Klein Lawrence Otto
Chief Executive Officer
—
$9.2M
-$9.2M
Quinlan Paul T
General Counsel
—
$7.4M
-$7.4M
Agarwal Arjun
Senior Vice President, Finance
—
$2.8M
-$2.8M
Goncalves Joana
Chief Medical Officer
—
$2.0M
-$2.0M
Sandler Laura Lee
Chief Operating Officer
—
$546K
-$546K
Edwards Larry Todd
Chief Commercial Officer
—
—
$0

Recent transactions

Every Form 4 transaction for ORKA, newest first.

SELL10b5-1
Quinlan Paul T · General Counsel
Tx Oct 20·Filed Oct 20·EDGAR ↗
4,100 sh @ $78.79
$323K
SELL10b5-1
Quinlan Paul T · General Counsel
Tx Oct 20·Filed Oct 20·EDGAR ↗
500 sh @ $76.12
$38K
SELL10b5-1
Quinlan Paul T · General Counsel
Tx Oct 20·Filed Oct 20·EDGAR ↗
3,000 sh @ $79.49
$238K
SELL10b5-1
Quinlan Paul T · General Counsel
Tx Oct 20·Filed Oct 20·EDGAR ↗
1,000 sh @ $77.20
$77K
EXERCISE10b5-1
Quinlan Paul T · General Counsel
Tx Oct 20·Filed Oct 20·EDGAR ↗
9,000 sh @ $7.80
$70K
SELL10b5-1
Quinlan Paul T · General Counsel
Tx Oct 20·Filed Oct 20·EDGAR ↗
400 sh @ $74.90
$30K
SELL10b5-1
Goncalves Joana · Chief Medical Officer
Tx Oct 15·Filed Oct 15·EDGAR ↗
700 sh @ $76.67
$54K
SELL10b5-1
Goncalves Joana · Chief Medical Officer
Tx Oct 15·Filed Oct 15·EDGAR ↗
2,853 sh @ $73.89
$211K
SELL10b5-1
Goncalves Joana · Chief Medical Officer
Tx Oct 15·Filed Oct 15·EDGAR ↗
200 sh @ $77.71
$16K
SELL10b5-1
Goncalves Joana · Chief Medical Officer
Tx Oct 15·Filed Oct 15·EDGAR ↗
1,400 sh @ $75.48
$106K
SELL10b5-1
Goncalves Joana · Chief Medical Officer
Tx Oct 15·Filed Oct 15·EDGAR ↗
1,847 sh @ $74.69
$138K
EXERCISE10b5-1
Goncalves Joana · Chief Medical Officer
Tx Oct 15·Filed Oct 15·EDGAR ↗
3,500 sh @ $6.84
$24K
EXERCISE10b5-1
Agarwal Arjun · Senior Vice President, Finance
Tx Oct 12·Filed Oct 13·EDGAR ↗
1,458 sh @ $34.39
$50K
SELL10b5-1
Agarwal Arjun · Senior Vice President, Finance
Tx Oct 12·Filed Oct 13·EDGAR ↗
5,741 sh @ $80.03
$459K
SELL10b5-1
Agarwal Arjun · Senior Vice President, Finance
Tx Oct 12·Filed Oct 13·EDGAR ↗
2,100 sh @ $80.76
$170K
SELL10b5-1
Agarwal Arjun · Senior Vice President, Finance
Tx Oct 12·Filed Oct 13·EDGAR ↗
200 sh @ $82.83
$17K
EXERCISE10b5-1
Agarwal Arjun · Senior Vice President, Finance
Tx Oct 12·Filed Oct 13·EDGAR ↗
8,541 sh @ $12.50
$107K
SELL10b5-1
Agarwal Arjun · Senior Vice President, Finance
Tx Oct 12·Filed Oct 13·EDGAR ↗
1,958 sh @ $81.86
$160K
SELL10b5-1
Klein Lawrence Otto · Chief Executive Officer
Tx Oct 1·Filed Oct 2·EDGAR ↗
16,246 sh @ $83.40
$1.4M
SELL10b5-1
Klein Lawrence Otto · Chief Executive Officer
Tx Oct 1·Filed Oct 2·EDGAR ↗
8,554 sh @ $84.03
$719K
SELL10b5-1
Klein Lawrence Otto · Chief Executive Officer
Tx Oct 1·Filed Oct 2·EDGAR ↗
200 sh @ $84.78
$17K
EXERCISE10b5-1
Klein Lawrence Otto · Chief Executive Officer
Tx Oct 1·Filed Oct 2·EDGAR ↗
25,000 sh @ $7.80
$195K
SELL10b5-1
Quinlan Paul T · General Counsel
Tx Sep 21·Filed Sep 21·EDGAR ↗
2,667 sh @ $95.31
$254K
SELL10b5-1
Quinlan Paul T · General Counsel
Tx Sep 21·Filed Sep 21·EDGAR ↗
601 sh @ $94.44
$57K
SELL10b5-1
Quinlan Paul T · General Counsel
Tx Sep 21·Filed Sep 21·EDGAR ↗
2,900 sh @ $92.37
$268K
EXERCISE10b5-1
Quinlan Paul T · General Counsel
Tx Sep 21·Filed Sep 21·EDGAR ↗
10,000 sh @ $7.80
$78K
SELL10b5-1
Agarwal Arjun · Senior Vice President, Finance
Tx Sep 21·Filed Sep 21·EDGAR ↗
533 sh @ $95.75
$51K
SELL10b5-1
Quinlan Paul T · General Counsel
Tx Sep 21·Filed Sep 21·EDGAR ↗
3,832 sh @ $93.32
$358K
SELL10b5-1
Goncalves Joana · Chief Medical Officer
Tx Sep 15·Filed Sep 15·EDGAR ↗
1,366 sh @ $92.99
$127K
SELL
Quinlan Paul T · General Counsel
Tx Sep 15·Filed Sep 15·EDGAR ↗
1,039 sh @ $95.71
$99K
SELL10b5-1
Agarwal Arjun · Senior Vice President, Finance
Tx Sep 15·Filed Sep 15·EDGAR ↗
560 sh @ $95.71
$54K
SELL
Klein Lawrence Otto · Chief Executive Officer
Tx Sep 15·Filed Sep 15·EDGAR ↗
2,452 sh @ $95.71
$235K
SELL10b5-1
Goncalves Joana · Chief Medical Officer
Tx Sep 15·Filed Sep 15·EDGAR ↗
3,150 sh @ $92.03
$290K
EXERCISE10b5-1
Goncalves Joana · Chief Medical Officer
Tx Sep 15·Filed Sep 15·EDGAR ↗
3,500 sh @ $6.84
$24K
SELL10b5-1
Goncalves Joana · Chief Medical Officer
Tx Sep 15·Filed Sep 15·EDGAR ↗
100 sh @ $94.22
$9K
SELL10b5-1
Goncalves Joana · Chief Medical Officer
Tx Sep 15·Filed Sep 15·EDGAR ↗
2,384 sh @ $91.10
$217K
SELL10b5-1
Goncalves Joana · Chief Medical Officer
Tx Sep 15·Filed Sep 15·EDGAR ↗
947 sh @ $95.71
$91K
SELL
Sandler Laura Lee · Chief Operating Officer
Tx Sep 15·Filed Sep 15·EDGAR ↗
906 sh @ $95.71
$87K
SELL10b5-1
Agarwal Arjun · Senior Vice President, Finance
Tx Sep 11·Filed Sep 15·EDGAR ↗
3,000 sh @ $91.11
$273K
SELL10b5-1
Agarwal Arjun · Senior Vice President, Finance
Tx Sep 11·Filed Sep 15·EDGAR ↗
4,051 sh @ $92.41
$374K
EXERCISE10b5-1
Agarwal Arjun · Senior Vice President, Finance
Tx Sep 11·Filed Sep 15·EDGAR ↗
1,459 sh @ $34.39
$50K
SELL10b5-1
Agarwal Arjun · Senior Vice President, Finance
Tx Sep 11·Filed Sep 15·EDGAR ↗
2,208 sh @ $93.26
$206K
SELL10b5-1
Agarwal Arjun · Senior Vice President, Finance
Tx Sep 11·Filed Sep 15·EDGAR ↗
200 sh @ $94.02
$19K
EXERCISE10b5-1
Agarwal Arjun · Senior Vice President, Finance
Tx Sep 11·Filed Sep 15·EDGAR ↗
8,000 sh @ $12.50
$100K
SELL10b5-1
Klein Lawrence Otto · Chief Executive Officer
Tx Sep 1·Filed Sep 1·EDGAR ↗
4,800 sh @ $92.44
$444K
SELL10b5-1
Sandler Laura Lee · Chief Operating Officer
Tx Sep 1·Filed Sep 1·EDGAR ↗
4,000 sh @ $92.01
$368K
EXERCISE10b5-1
Sandler Laura Lee · Chief Operating Officer
Tx Sep 1·Filed Sep 1·EDGAR ↗
5,000 sh @ $7.80
$39K
EXERCISE10b5-1
Klein Lawrence Otto · Chief Executive Officer
Tx Sep 1·Filed Sep 1·EDGAR ↗
75,000 sh @ $7.80
$585K
SELL10b5-1
Sandler Laura Lee · Chief Operating Officer
Tx Sep 1·Filed Sep 1·EDGAR ↗
1,000 sh @ $91.05
$91K
SELL10b5-1
Klein Lawrence Otto · Chief Executive Officer
Tx Sep 1·Filed Sep 1·EDGAR ↗
63,596 sh @ $91.90
$5.8M

Track every ticker you care about

Free plan includes 3 tickers, daily insider scans, and cluster alerts. No credit card.

Start free (3 tickers)See plans

Join investors tracking SEC filings.

About ORKA insider trading data

Form 4 is the SEC filing required when an officer, director, or 10% owner of a public company buys or sells the company's stock. By law, these filings must be submitted within two business days of the trade. Tracenotes pulls every Form 4 filing for ORKA from EDGAR, parses it, and surfaces the activity on this page.

What insider buying tells you. Open-market purchases by insiders are widely studied as a meaningful signal. Unlike stock awards (which are compensation, not conviction), an executive spending their own money to buy shares of the company they run is a vote of confidence. Studies have found insider-buying clusters — three or more insiders buying within a short window — outperform the broader market over the following year.

What insider selling tells you. Selling is noisier. Many sales are pre-scheduled under SEC Rule 10b5-1 plans, which let insiders sell on a fixed schedule regardless of company news. We label these "10b5-1" so you can see them. Discretionary sales — sales not tied to a plan — are more meaningful, especially when multiple insiders sell in quick succession.

Tracenotes methodology. We scan EDGAR daily for new Form 4 filings, parse them into individual transactions, and detect clusters when three or more distinct insiders buy or sell within a 14-day window. The data on this page covers the last 12 months. For deeper analysis, Tracenotes also runs language-change detection on 10-K and 10-Q filings — that's our core product.

See this for every ticker.

Tracenotes covers the S&P 500 and beyond. Pick any ticker — get the same depth of insider trading data.

AAPLNVDAMSFTTSLA

Free plan available — no credit card. Sign up free →

Frequently asked questions

What is a Form 4 filing?

Form 4 is the SEC disclosure required when a company insider — an officer, director, or 10% owner — buys or sells the company's stock. By law these filings must be submitted within two business days of the trade.

Is insider buying ORKA always bullish?

Open-market purchases by insiders are widely viewed as a bullish signal because executives are spending their own money. Stock awards and option exercises are part of compensation and don't carry the same weight, which is why we treat them separately on this page.

What is a 10b5-1 trade?

A trade made under SEC Rule 10b5-1, which lets insiders pre-schedule sales weeks or months in advance. These sales execute on a fixed plan regardless of company news, so they're a weaker signal than discretionary sales. We label them with a "10b5-1" tag.

What is an insider cluster?

A cluster is when three or more distinct insiders buy or sell within a 14-day window. Clusters are studied as stronger signals than single trades because multiple people independently reach the same view. We surface active clusters on Oruka Therapeutics, Inc. (ORKA) when they form.

Where does ORKA insider trading data come from?

Every Form 4 filing for ORKA is sourced directly from SEC EDGAR. Tracenotes scans EDGAR daily, parses each Form 4 into individual transactions, and updates this page within hours of new filings.

Nothing on this page constitutes investment advice. Form 4 data is sourced from SEC EDGAR and provided for research purposes only.

© 2026 Tracenotes · tracenotes.ai